Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 38.90
+0.15 (0.39%)
Sep 30, 2026, 1:30 PM CST
Qing Song Health Market Cap
Qing Song Health has a market cap or net worth of 2.56 billion as of September 29, 2026. Its market cap has decreased by -24.61% in one year.
Market Cap
2.56B
Enterprise Value
2.89B
Revenue
1.21B
Ranking
n/a
PE Ratio
10.31
Stock Price
38.90
ChartMarket Cap Chart
Since December 27, 2022, Qing Song Health's market cap has increased from 2.32B to 2.56B, an increase of 10.51%. That is a compound annual growth rate of 2.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.56B | -38.39% |
| Dec 31, 2025 | 4.16B | -29.22% |
| Dec 31, 2024 | 5.88B | 28.33% |
| Dec 29, 2023 | 4.58B | 120.52% |
| Dec 30, 2022 | 2.08B | -10.44% |
| Dec 27, 2022 | 2.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 478.67B |
| Lin BioScience | 164.18B |
| Caliway Biopharmaceuticals | 124.59B |
| Heron Neutron Medical | 78.68B |
| Intech Biopharm | 2.63B |
| ShareHope Medicine | 2.61B |
| Chunghwa Chemical Synthesis & Biotech | 2.59B |
| Merdury Biopharmaceutical | 2.57B |